Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Share Price
Equities
600329
CNE000001808
Pharmaceuticals
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 41.87 CNY | +2.12% |
|
-3.08% | -8.22% |
| Capitalization | 2.84TCr 411.95Cr 354.59Cr 319.51Cr 307.15Cr 558.92Cr 38TCr 585.98Cr 3.78TCr 1.51TCr 18TCr 1.55TCr 1.51TCr 65TCr | P/E ratio 2025 * |
13.9x | P/E ratio 2026 * | 28.7x |
|---|---|---|---|---|---|
| Enterprise value | 2.84TCr 411.95Cr 354.59Cr 319.51Cr 307.15Cr 558.92Cr 38TCr 585.98Cr 3.78TCr 1.51TCr 18TCr 1.55TCr 1.51TCr 65TCr | EV / Sales 2025 * |
5.79x | EV / Sales 2026 * | 5.31x |
| Free-Float |
31.72% | Yield 2025 * |
-
| Yield 2026 * | - |
| 1 day | +2.12% | ||
| 1 week | -3.08% | ||
| Current month | -2.65% | ||
| 1 month | -8.82% | ||
| 3 months | -9.94% | ||
| 6 months | -8.80% | ||
| Current year | -8.22% |
| 1 week | 40.7 |  | 42.75 |
| 1 month | 40.7 | | 47.85 |
| Current year | 40.7 | | 48.2 |
| 1 year | 28.53 | | 50.97 |
| 3 years | 23.4 | | 56.26 |
| 5 years | 17.5 | | 56.26 |
| 10 years | 11.8 | | 56.26 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jian Ma
DFI | Director of Finance/CFO | 48 | 21/07/2023 |
Hong Zhou
CTO | Chief Tech/Sci/R&D Officer | 56 | 10/10/2017 |
Jian Wang
IRC | Investor Relations Contact | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Lei Wang
CHM | Chairman | 55 | 26/11/2024 |
Hong Zhou
BRD | Director/Board Member | 56 | 01/12/2012 |
Yoke Pheng Liew
BRD | Director/Board Member | 70 | 05/06/2020 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.12% | -3.08% | +39.20% | +19.73% | 404.78Cr | |
| +1.01% | -1.83% | -17.30% | -38.23% | 591.48Cr | |
| +0.04% | -3.22% | -7.13% | +11.21% | 490.2Cr | |
| +1.95% | -4.12% | +19.71% | -44.47% | 398.57Cr | |
| +0.84% | +0.69% | +1.02% | -3.78% | 367.94Cr | |
| +2.38% | -2.87% | -5.45% | +2.45% | 301.12Cr | |
| +2.70% | -1.59% | +11.76% | -17.64% | 249.13Cr | |
| +0.04% | +1.18% | +12.48% | +0.32% | 206.25Cr | |
| +0.89% | -0.09% | +3.86% | +36.14% | 174.23Cr | |
| +1.37% | -3.16% | +10.25% | +33.33% | 161.15Cr | |
| Average | +1.33% | -1.04% | +6.84% | -0.09% | 334.49Cr | |
| Weighted average by Cap. | +1.30% | -1.18% | +4.95% | -6.03% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 490.8Cr 71Cr 61Cr 55Cr 53Cr 97Cr 6.54TCr 101.24Cr 652.99Cr 261.16Cr 3.14TCr 267.11Cr 261.41Cr 11TCr | 534.8Cr 78Cr 67Cr 60Cr 58Cr 105.22Cr 7.13TCr 110.32Cr 711.53Cr 284.58Cr 3.42TCr 291.05Cr 284.84Cr 12TCr |
| Net income | 232.5Cr 34Cr 29Cr 26Cr 25Cr 46Cr 3.1TCr 48Cr 309.33Cr 123.72Cr 1.49TCr 126.53Cr 123.83Cr 5.32TCr | 112.4Cr 16Cr 14Cr 13Cr 12Cr 22Cr 1.5TCr 23Cr 149.54Cr 60Cr 718.06Cr 61Cr 60Cr 2.57TCr |
| Net Debt | - | - |
Employees
4,619
Sector
Pharmaceuticals
Calendar
31/03 -
Earnings release - Annual 2025
| Date | Price | Change | Volume |
|---|---|---|---|
| 06/26/06 | 41.87 ¥ | +2.12% | 30,33,052 |
| 05/26/05 | 41.00 ¥ | +0.42% | 28,89,840 |
| 04/26/04 | 40.83 ¥ | -1.14% | 33,64,340 |
| 03/26/03 | 41.30 ¥ | -2.16% | 47,08,826 |
| 02/26/02 | 42.21 ¥ | -1.86% | 44,09,874 |
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
41.87
Average target price
-
Annual profits - Rate of surprise
- Stock Market
- Equities
- 600329 Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition